2043. In Vitro Activity of Manogepix Against 2,810 Fungal Isolates from the SENTRY Surveillance Program (2020-2021) Stratified by Infection Type

BACKGROUND: Manogepix is a new antifungal with a novel mechanism of action and potent in vitro activity against Candida (except C. krusei), Aspergillus, and rare mold isolates. The manogepix prodrug fosmanogepix is in Phase 2 development for the treatment of invasive mold infections caused by Asperg...

Descripción completa

Detalles Bibliográficos
Autores principales: Huband, Michael D, Pfaller, Michael, Carvalhaes, Cecilia G, Bien, Paul, Castanheira, Mariana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752681/
http://dx.doi.org/10.1093/ofid/ofac492.1665

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752681/
http://dx.doi.org/10.1093/ofid/ofac492.1665

Ejemplares similares